skip to content
Systematic Reviews of Treatments for Ovarian Cancer
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for ovarian cancer.
Reviewed December 2011
21 Resources Found
Results 1 to 20 displayed. 1 2
| Title: | Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer commonly spreads through the peritoneal cavity and usually responds to intravenous (IV) chemotherapy. This review compared the effectiveness of IV chemotherapy to chemotherapy administered directly into the peritoneal cavity (intraperito... |
| Date: | Sep 2011 |
| Title: | Angiogenesis inhibitors for the treatment of ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is the seventh most common cancer in women worldwide, with an annual incidence of about 6.3 cases per 100,000 women, and an annual mortality rate of 3.8 per 100,000 women. Standard treatment of advanced ovarian cancer usually involves sur... |
| Date: | Jul 2011 |
| Title: | Optimal primary surgical treatment for advanced epithelial ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is a cancerous growth arising from different parts of the ovary. It is the sixth most common cancer among women. Most ovarian cancers are classified as epithelial. Ovarian epithelial cancer is a disease in which malignant (cancer) cells f... |
| Date: | Jun 2011 |
| Title: | Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is the sixth most common cancer and seventh commonest cause of cancer death in women worldwide. Traditionally, many patients who have been treated for cancer undergo long-term follow up in hospitals. Whilst there may be other benefits fro... |
| Date: | May 2011 |
| Title: | Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is the commonest cause of death in women with a female cancer. Opinions differ about whether women with advanced ovarian cancer do better if they have 'ultra-radical' surgery which is much more extensive than standard surgery. We system... |
| Date: | Mar 2011 |
| Title: | Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Malignant germ cell cancer of the ovary (type of ovarian cancer) is a very rare type of cancer. Malignant ovarian germ cell cancer is a term used to describe a group of heterogeneous rare tumours affecting the ovaries. These tumours start in the egg (ov... |
| Date: | Feb 2011 |
| Title: | Interval debulking surgery for advanced epithelial ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer frequently presents at an advanced stage so it may not be possible to remove all tumours during surgery. Several cycles of chemotherapy are generally given after primary surgery. Secondary surgery, performed after a few cycles of chemothe... |
| Date: | Aug 2010 |
| Title: | Maintenance chemotherapy for ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Of all the gynaecological cancers, ovarian cancer has the highest death rate and epithelial ovarian cancer accounts for about 90% of all cases. Surgery and six courses of platinum-based chemotherapy is the standard treatment and 75% of the women may not... |
| Date: | Aug 2010 |
| Title: | Interventions for the treatment of borderline ovarian tumours |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with borderline (low malignant potential) ovarian tumours do very well after surgery and recurrences may be cured by further surgery. The ideal form of initial surgical treatment for borderline ovarian tumours is controversial. Furthermore, it is ... |
| Date: | Jul 2010 |
| Title: | Palliative surgery versus medical management for bowel obstruction in ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is the sixth most common cancer among women and is usually diagnosed at an advanced stage. Bowel obstruction is a common feature of advanced or recurrent ovarian cancer and causes vomiting, pain and diarrhoea. Patients with bowel obstruct... |
| Date: | Jun 2010 |
| Title: | DNA-repair pathway inhibitors for the treatment of ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is the sixth commonest cancer in women world-wide and remains a leading cause of death, with an annual incidence of 6.6 cases per 100,000 women and an annual mortality rate of 4.0 deaths per 100,000 women. Most ovarian cancers (90%) are e... |
| Date: | May 2010 |
| Title: | Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer is the sixth most common cancer among women. Epithelial ovarian cancer is a disease in which malignant cells form in the tissue covering the ovary. It accounts for about 90% of ovarian cancers., the remaining 10% arise from germ cells and... |
| Date: | May 2010 |
| Title: | Tamoxifen for relapse of ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian cancer often spreads before symptoms show. Cytotoxic drugs are often only partly effective and cause severe side-effects. The main aims of treatment for relapsed disease are symptom control and prolongation of life. No data from RCTs or non-RCTs... |
| Date: | Feb 2010 |
| Title: | Antigen-specific active immunotherapy for ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Epithelial ovarian cancer is the most frequently diagnosed ovarian malignancy and the leading cause of death from gynaecological cancers. Standard therapy consists of surgery followed by chemotherapy. Although initial response rates are high, the majori... |
| Date: | Oct 2009 |
| Title: | Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Controversial discussion has arisen among endoscopists and oncologists about the laparoscopic management of early stage ovarian tumours. This systematic review found no evidence to help quantify the value of laparoscopy for the management of early stage... |
| Date: | Jul 2008 |
| Title: | Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Chemotherapy with platinum containing drugs given after surgery to remove ovarian cancers that have not spread beyond the pelvis saves lives but is probably unnecessary when the tumour is proven to have not spread outside of the ovary, particularly if t... |
| Date: | Jun 2008 |
| Title: | Topotecan for ovarian cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | It appears to have a similar level of effectiveness as paclitaxel and pegylated liposomal doxorubicin, though with different patterns of side effects. Larger, well-designed randomised controlled trials (RCTs) are required to define an optimal regime. |
| Date: | Feb 2008 |
| Title: | Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Corticosteroids may reduce bowel obstruction for people with advanced gastrointestinal or ovarian cancer. Malignant bowel obstruction is fairly common in people with gastrointestinal (gut) cancer or ovarian cancer. It can lead to pain, vomiting, nausea,... |
| Date: | Feb 2008 |
| Title: | Laparoscopy versus laparotomy for benign ovarian tumour |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Laparoscopy is a modern surgical technique in which operations are performed through small incisions (usually 2 to 3 cm long) using a laparoscope. This is a telescopic rod lens system that is usually connected to a video camera. In the 12 controlled stu... |
| Date: | Nov 2007 |
| Title: | Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Epithelial ovarian cancer is the sixth commonest cancer world-wide and is the commonest form of ovarian cancer (approximately 90% of ovarian cancers). Unfortunately most women with ovarian cancer (75%) present at a late stage when their disease has spre... |
| Date: | Jul 2007 |
Results 1 to 20 displayed. 1 2
